fk 3311 has been researched along with Ischemia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aiba, M; Iwazaki, S; Kasahara, M; Kawashima, Y; Kawate, S; Matsumoto, K; Morishita, Y; Ogawa, T; Ohwada, S; Sunose, Y; Takeyoshi, I; Tomizawa, N; Tsutsumi, H | 2 |
Iwazaki, S; Kawata, K; Matsumoto, K; Morishita, Y; Ohwada, S; Sunose, Y; Takeyoshi, I; Tokumine, M; Tomizawa, N; Tsutsumi, H | 1 |
3 other study(ies) available for fk 3311 and Ischemia
Article | Year |
---|---|
The effect of cyclooxygenase 2 inhibitor (FK3311) on ischemia-reperfusion injury with hepatectomy in dogs.
Topics: Anilides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspartate Aminotransferases; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dogs; Female; Hepatectomy; Ischemia; Isoenzymes; Liver; Liver Circulation; Male; Prostaglandin-Endoperoxide Synthases; Regional Blood Flow; Reperfusion Injury | 2000 |
Effect of FK3311 on ischemia-reperfusion injury in canine pulmonary models.
Topics: Anilides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cardiac Output; Dogs; Hemodynamics; Ischemia; Lung; Models, Animal; Oxygen; Partial Pressure; Pulmonary Artery; Pulmonary Circulation; Pulmonary Veins; Reference Values; Reperfusion Injury; Thromboxane B2; Vascular Resistance | 2000 |
Effects of FK3311 on pulmonary ischemia-reperfusion injury in a canine model.
Topics: 6-Ketoprostaglandin F1 alpha; Anilides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cardiac Output; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dogs; Epoprostenol; Hemodynamics; Ischemia; Isoenzymes; Lung; Neutrophils; Oxygen; Partial Pressure; Prostaglandin-Endoperoxide Synthases; Pulmonary Artery; Pulmonary Circulation; Pulmonary Veins; Reperfusion Injury; Thromboxane B2; Time Factors; Vascular Resistance | 2001 |